PainWeek 2017

PainWeek 2017 Coverage

What's New in Pain Management: New Medications, Drugs in the Pipeline

By Tori Rodriguez, MA, LPC September 09, 2017

Multiple new drugs for pain management have been recently introduced or approved, and additional agents are currently under investigation.

'Opioid McCarthyism' Addressed in PAINWeek 2017 Keynote Lecture

By Florence Chaverneff, PhD September 08, 2017

Dr Zacharoff provided advice for clinicians dealing with fluid guidelines and constraints regarding opioid prescribing.

Combo Treatment May Benefit Patients with Fibromyalgia and PTSD

By Brandon May September 08, 2017

In patients with concomitant fibromyalgia and PTSD, opioid therapy was shown to improve quality of life and help patients return to a greater sense of "normalcy."

Postoperative Opioid Associated Nausea, Vomiting Risks Examined

September 08, 2017

Opioid treatment of acute postoperative pain was shown to cause high rates of postoperative nausea and vomiting, particularly in women and younger patients.

Doxepin Evaluated for Sleep Disturbances in Patients with Chronic Pain

By September 08, 2017

Compared with placebo, data for the 3mg, 6mg, and combined active doxepin treatment groups significantly improved all PSG and subjective evaluated sleep outcomes for all days and nights up to Night 30.

Risks of Concomitant Benzodiazepine, Opioid Rx Among the Elderly

By Florence Chaverneff, PhD September 08, 2017

Dr Gould covered the risks of co-prescribing benzodiazepines and opioids, particularly for elderly patients, and proposed therapeutic alternatives at PAINWeek 2017.

Efficacy of Abuse-Deterrent Morphine, Oxycodone Assessed

By Brandon May September 08, 2017

The researchers presented examined the effects of 66mg intact oral morphine ARER, 60mg crushed intranasal morphine ARER, 60mg crushed intranasal morphine ER, 30mg intact oral oxycodone ARIR, 30mg crushed intranasal oxycodone ARIR, and 30mg crushed intranasal IR oxycodone or placebo among nondependent recreational opioid users.

Pain Management Strategies to Reduce Overdose Risks

By Tori Rodriguez, MA, LPC September 08, 2017

At PAINWeek 2017, the president of the National Association of Drug Diversion Investigators discussed ways to balance pain management needs and overdose prevention measures.

Naldemedine Effective for Treating Opioid-Induced Constipation

By Jessica Martin September 08, 2017

In patients with opioid-induced constipation, naldemedine was shown to improve patient assessment of symptoms and quality of life.

What Are Clinicians Prescribing for Headache and Migraine?

By September 07, 2017

Results of the study found that only 4% of H only patients used triptan medications compared to 46-50% of patients in the other 4 groups.